Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

10836	Companies
235277	Keywords
164215	Articles
126032	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 03/27/2024 at 11:30, 2 years 4 months ago

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Moderna announces successful clinical readouts for fourth respiratory vaccine candidate meeting Phase 3 endpoints and provides updates on vaccine portfolios, clinical trials, and financial agreements at fifth Vaccines Day event

Clinical Trials Moderna Vaccine Phase 3 Respiratory
BRIEF

published on 03/26/2024 at 12:05, 2 years 4 months ago

Moderna Reports Positive Results in Phase 3 Trial of New COVID-19 Vaccine

Public Health COVID-19 Vaccine Moderna Phase 3 Trial MRNA-1283
PRESS RELEASE

published on 03/26/2024 at 12:00, 2 years 4 months ago

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Moderna's mRNA-1283 shows higher immune response than mRNA-1273.222 in Phase 3 trial. Next-generation vaccine offers longer shelf life and storage benefits, paving way for flu-COVID combo vaccine, mRNA-1083

COVID-19 Vaccine Moderna Phase 3 Trial MRNA-1283 MRNA-1273.222
BRIEF

published on 02/29/2024 at 13:00, 2 years 5 months ago

Moderna Announces Fifth Annual Vaccine-Focused Investor Event

Investors Webcast Moderna Investor Event MRNA Vaccines
PRESS RELEASE

published on 02/29/2024 at 13:00, 2 years 5 months ago

Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024
Moderna, Inc. announces its fifth annual Investor Event focusing on vaccines and business updates on March 27, 2024. Presentation at 9:00 a.m. ET. Live webcast available on the Moderna website

Webcast MRNA Medicine Moderna Investor Event MRNA Vaccines
BRIEF

published on 02/28/2024 at 13:00, 2 years 5 months ago

Moderna announces participation in investor conferences

Investor Conferences Webcast MRNA Technology Moderna Health
PRESS RELEASE

published on 02/28/2024 at 13:00, 2 years 5 months ago

Moderna to Present at Upcoming Investor Conferences in March 2024
Moderna, Inc. to participate in upcoming investor conferences and showcase advancements in mRNA technology. Visit investors.modernatx.com for webcast details

Investor Conferences Healthcare Moderna Inc. MRNA Technology COVID-19 Vaccines
BRIEF

published on 02/22/2024 at 12:30, 2 years 5 months ago

Moderna announces mixed financial results for 2023 and optimistic outlook for 2024

2023 Financial Results 2024 Forecasts Moderna RSV Vaccine Research Pipeline
PRESS RELEASE

published on 02/22/2024 at 12:30, 2 years 5 months ago

Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $2.8 billion with a GAAP net income of $217 million. Expects regulatory approvals for RSV vaccine and forecasts 2024 product sales of $4 billion

Financial Results Moderna Inc. RSV Vaccine Product Sales Regulatory Approvals
PRESS RELEASE

published on 02/07/2024 at 06:00, 2 years 6 months ago

Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Moderna, Inc.'s CEO Stéphane Bancel elected to National Academy of Engineering for distinguished contributions to engineering and manufacturing of pharmaceutical products, including COVID-19 vaccine. Company has 45 mRNA therapeutic and vaccine programs in pipeline

Moderna Inc COVID-19 Vaccine Stéphane Bancel National Academy Of Engineering MRNA Technology

Accesswire

Published on 08/15/2026 at 00:50, 16 hours 10 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 16 hours 45 minutes ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 17 hours 15 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 17 hours 35 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 18 hours ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/15/2026 at 15:05, 1 hour 55 minutes ago

Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 8 hours 55 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 22 hours 31 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 22 hours 45 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 1 day ago

GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON

Les Echos

Published on 08/10/2026 at 18:00, 4 days 23 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 4 days 23 hours ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 5 days 5 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 5 days 5 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 5 days 7 hours ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE